Experiment 67351

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationLAL,B: KAPOOR,AK: AGRAWAL,PK: ASTHANA,OP: SRIMAL,RC:. (2000). ROLE OF CURCUMIN IN IDIOPATHIC INFLAMMATORY ORBITAL PSEUDOTUMOURS.. 14(6)
Amount utilized
Compound isolated
DiseaseTHE REPORT DESCRIBES THE CLINICAL EFFICACY OF CURCUMIN IN THE TREATMENT OF PATIENTS SUFFERING FROM IDIOPATHIC INFLAMMATORY ORBITAL PSEUDOTUMOURS. CURCUMIN WAS ADMINISTERED ORALLY AT A DOSE OF 375 MG/3TIMES/DAY ORALLY FOR A PERIOD OF 6-22 MONTHS IN EIGHT PATIENTS. THEY WERE FOLLOWED UP FOR A PERIOD OF 2 YEARS AT 2 MONTHLY INTERVALS. FIVE PATIENTS COMPLETED THE STUDY, OUT OF WHICH FOUR RECOVERED COMPLETELY AND IN ONE PATIENT THE SWELLING REGRESSED COMPLETELY BUT SOME LIMITATION OF MOVEMENT PERSISTED. NO SIDE EFFECT WAS NOTED IN ANY PATIENT AND THERE WAS NO RECURRENCE.
Dose amount1.125 GM
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES